RT @ejdein1: OPO132: Dr. Werth presents Iberdomide targeting cereblon ligand on SLE skin. Iberdomide 0.45 mg QD showed i

Social Author Image

https://pbs.twimg.com/profile_images/1322922848810422289/oM4qP9_k.jpg

Tweet Author

Social Author Name

Eric Dein

Tweet Content

OPO132: Dr. Werth presents Iberdomide targeting cereblon ligand on SLE skin. Iberdomide 0.45 mg QD showed improvement vs PBO for SCLE & CCLE, not seen for ACLE. Interesting new target, affects B cell and type 1 IFN pathways @Rheumnow #Eular2021 https://t.co/nuDM7h59MB

Show on Archive Page

On

Display in Search Results

On

PDQ

Off

Topics

RT @ejdein1: OPO132: Dr. Werth presents Iberdomide targeting cereblon ligand on SLE skin. Iberdomide 0.45 mg QD showed i

Do you get our email newsletter?